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Abstract 19 
Aims: Myocardial structural and functional abnormalities are known to occur in 20 
fetuses of maternal diabetes mellitus (FMDM) and in their offspring. The main 21 
aim of this investigation was to explore the cardiovascular circulatory patterns in 22 
FMDM using a validated lumped computational model of the cardiovascular 23 
system. 24 
Methods: This was a multi-institutional study involving FMDM compared to 25 
fetuses of maternal controls (FC). Fetal echocardiographic Doppler data from left 26 
and right ventricular outflow tracts, aortic isthmus, middle cerebral and umbilical 27 
arteries were fitted into a validated fetal circulation computational model to 28 
estimate patient-specific placental and vascular properties. Non-parametric 29 
comparisons were made between resistances, compliances and flows in the 30 
brain and placenta in FMDM and FC. 31 
Results: Data from 23 FMDM and 31 FC were fitted into the model. In FMDM, 32 
compared to FC, placental relative resistance was lower (0.59+0.50 versus 33 
0.91+0.41; p<0.05) with higher brain relative resistance (2.36+1.65 versus 34 
1.60+0.85; p<0.05). Middle cerebral artery flow was lower in FMDM than FC 35 
(0.12+0.14 vs. 0.27+0.21 ml/min; p 0.04) with a lower cerebral-placental flow 36 
ratio. Combined stroke volume was lower in FMDM (3.65+2.05 ml) than FC 37 
(4.97+2.45 ml) (p 0.04). 38 
Conclusions: Blood flow is redistributed in FMDM to the placenta, away from the 39 
brain. This alteration may play a role in the postnatal health of these fetuses. 40 
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Introduction 48 
Significant short and long-term morbidities have been known to occur in the 49 
offspring of mothers with diabetes mellitus. There is a five-fold increase in the risk 50 
of congenital heart disease in fetuses of mothers with diabetes mellitus (FMDM); 51 
they also have a higher incidence of a reversible hypertrophic cardiomyopathy 52 
and subclinical myocardial dysfunction.[1-3] Maternal diabetes mellitus (MDM) 53 
has been linked to fetal macrosomia, fetal growth restriction (FGR), and fetal and 54 
neonatal demise.[4] There also may be other lasting effects in these offspring 55 
including a propensity for neurological deficits, obesity, diabetes, hypertension 56 
and cardiovascular events later in life.[4-6]  57 
Current knowledge of the underlying mechanism of disease in FMDM suggests a 58 
combination of chemical, molecular and epigenetic influences on the fetus and 59 
placenta.[4, 7-9] Animal studies have shown that fetuses of hyperglycemic dams 60 
have reduced pancreatic β cell mass and reduced expression of insulin like 61 
growth factor.[10] Increased villous stromal capillarization and concentration of 62 
endogenous nucleoside adenosine (a potent vasodilator and anti-inflammatory 63 
agent) are seen in the placentae of FMDM.[11, 12] Rodent experiments have 64 
noted lower number of nephrons in the neonatal kidneys of MDM.[4] It is likely 65 
that these alterations in the fetal organ systems are associated with circulatory 66 
adaptations in FMDM. Computational modeling of the fetal circulation allows 67 
assessment of the relevant parameters non-invasively and in their natural 68 
environment in human fetuses.  69 
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A lumped model of the fetal circulation was created, validated and explored in 70 
FGR fetuses (implemented in Simulink, MATLAB 2013b, The MathWorks Inc., 71 
Natick, MA).[13, 14] This model provides a good non-invasive approximation of 72 
the fetal circulation to study hemodynamic changes induced by abnormal growth 73 
conditions. Alterations in fetal hemodynamics (predominantly flows) can be 74 
assessed non-invasively in clinical practice by localized Doppler measurements. 75 
However, computational models have the advantage of providing a more global 76 
view on hemodynamics as well as allowing the quantification of circulatory 77 
parameters that are currently not measurable non-invasively, such as pressures 78 
and vascular or organ properties like resistance and compliance. We applied this 79 
model to FMDM and compared them to normal fetal controls to understand if 80 
there were circulatory remodeling patterns in FMDM. This is a pilot study with an 81 
exploratory hypothesis that the circulatory systemshemodynamics/blood flow 82 
circulation in FMDM and FC may be different. 83 
Methods 84 
Study Population 85 
This was a cross-sectional multi-institutional case control study of 54 fetuses, 23 86 
FMDM) and 31 fetuses of control mothers (FC). The cases were enrolled from 87 
2013 to 2016; these were compared to normal fetal controls (FC) recruited from 88 
2012 to 2016. Of the 23 FMDM, 18 were recruited at Bronx Lebanon 89 
Hospital Center, Bronx, New York (Center 1), the remaining 5 were enrolled at 90 
Barcelona Center for Fetal and Neonatal Medicine (Center 2). Of the 31 FC, 9 91 
were enrolled at Center 1 and the remaining at Center 2. All mothers were 92 
 6 
referred for standard of care clinical indications.[15] Fetuses with arrhythmias, 93 
congenital heart disease, known genetic and chromosomal abnormalities, and 94 
multiple gestations were excluded. Singleton fetuses of mothers with DM and 95 
with structurally normal hearts without hypertrophy were included as cases, if the 96 
mothers agreed to participate and signed an informed consent. Cardiac 97 
hypertrophy was assessed based on gestational age and previously published 98 
nomograms.[16] Singleton fetuses of mothers without DM, with structurally and 99 
functionally normal hearts, and with the following additional inclusion criteria were 100 
included as FC: 101 
a) Estimated fetal weight within the 10th and 90th percentiles. 102 
b) No history of medical, surgical or obstetric complications. 103 
Gestational age was based on the beginning of the last menstrual period and 104 
verified by sonographic measurement of the crown-rump length in early 105 
pregnancy. The Institutional Review Boards at both institutions approved the 106 
study protocols.  107 
Estimated fetal weight (EFW) was calculated from the biparietal diameter, head 108 
and abdominal circumference, and femur length using the Hadlock formula.[17] 109 
Umbilical artery (UA) Doppler was evaluated in a free loop of the umbilical cord. 110 
Middle cerebral artery (MCA) Doppler was measured in a transverse view of the 111 
fetal skull at the level of its origin from the circle of Willis.[18] Aortic isthmus (AoI) 112 
flow velocity was recorded either in a sagittal view of the fetal thorax with a clear 113 
visualization of the aortic arch or in a cross section of the fetal thorax at the level 114 
of the 3-vessel and trachea view. Pulse wave Doppler velocity waveforms of the 115 
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left ventricular outflow tract (LVOT) were obtained in the 5-chamber view and of 116 
the right ventricular outflow tract (RVOT) were obtained from the short axis of the 117 
fetal heart in sagittal section. Doppler tracings were recorded with the sample 118 
volume positioned just proximal to the valve in the center of the vessel. The angle 119 
of insonation between the vessel and the Doppler beam was kept as close as 120 
possible to 0º and always below 30º. Diameters of the aortic and pulmonary 121 
artery valves were measured in frozen real-time magnified images during systole 122 
by the leading edge-to-edge method.[19]  123 
Lumped Model of Fetal Circulation 124 
Details of the fetal lumped computational model and its validation have been 125 
published previously.[13, 14] A brief description is provided here. The electrical 126 
equivalent model of the different compartments of the fetal circulation was 127 
constructed using two main building blocks of the arterial segments and 128 
peripheral vascular beds. The arterial segments were configured to include the 129 
local resistance of blood due to blood viscosity that was modeled with a resistor, 130 
the arterial compliance was modeled with a capacitor and the blood inertia was 131 
modeled with an inductor. The peripheral vascular bed was constructed based on 132 
a three-element Windkessel model. The simplified fetal circulation was modeled 133 
as a set of 19 arterial segments and 12 vascular beds as described 134 
previously.[13] The amount of blood flow that was distributed towards different 135 
fetal areas, including the brain, the placenta and the coronary arteries, was 136 
calculated as the percentage of combined cardiac output (CCO). For the 137 
purposes of this study, both FMDM and FC Doppler data were fitted to the 138 
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validated model. Physical dimensions of all arterial segments were calculated 139 
relative to the expected value from gestational age of the fetus using previously 140 
published equations.[13, 14] Changes in length and diameter of the fetal arterial 141 
segments, vascular bed resistances and compliances were scaled as a function 142 
of the EFW too, as described in previous publications from this group and 143 
reference data.[14, 20] The patient-specific model fitting was done by means of 144 
an optimization algorithm in which a set of 13 parameters were estimated 145 
automatically by minimizing the difference of model-based and measured flow 146 
waveforms in the study cohort. Statistical comparisons were made from the 147 
simulation outputs between FMDM and FC to assess differences.  148 
Statistical Analysis 149 
Descriptive data were expressed as mean + standard deviation. Kolmogorov-150 
Smirnov test were conducted in all variables to test for normality. Two-tailed t-test 151 
comparisons were made for normally distributed data and Mann-Whitney U test 152 
was used for non-parametric data comparisons. All tests of statistical significance 153 
were two-sided and a p value < 0.05 was considered significant. Linear 154 
regression analysis was performed in FMDM and FC groups for some key 155 
parameters to determine the effects of gestation age on the variables (Table 4). 156 
Also, liner regression including all the data (FMDM and FC) and an interaction 157 
term between GA and case group was performed to evaluate the relationship 158 
between gestational age and some key model parameters. All statistical analyses 159 




Data from 23 FMDM and 31 FC were used to create a personalized fetal 163 
circulation computational model. The baseline characteristics in the two groups 164 
are detailed in table 1. The median gestational age (weeks) was similar in FMDM 165 
and FC. Overall, in the FMDM, 17 mothers were controlled on insulin (10 mothers 166 
had type 2 DM, 4 had type 1 DM, 3 had gestational DM), 4 on oral medications 167 
(all mothers had gestational diabetes) and 2 were controlled on diet alone (2 had 168 
gestational DM). Mean maternal BMI in FMDM group was significantly higher 169 
than the FC group. Two mothers in the FMDM group had additional co-170 
morbidities of chronic hypertension, three mothers had pre-pregnancy 171 
hypothyroidism and one mother had genetic prothrombin deficiency. None of the 172 
mothers in the FC group had additional co-morbidities. The estimated fetal 173 
weights (grams) were similar between the two groups. All fetuses were born full 174 
term (>37 weeks gestation), except for one born premature at 31 weeks 175 
gestation in the FMDM group and one in the FC group at 30 weeks 6 days. Birth 176 
weights were also similar in both groups. 177 
Table 2 shows the results of the hemodynamic parameters that were measured 178 
and modeled from the echocardiographic data. There were significant differences 179 
in the baseline parameters for the velocity time integrals (VTI) of the left and right 180 
ventricular outflow tracts (LV_VTI: VTI of left ventricular outflow tract Doppler, 181 
RV_VTI: VTI of right ventricular outflow tract Doppler) measured from the 182 
recorded fetal Doppler echocardiograms between the two groups. Right 183 
ventricular stroke volume (RVSV) and total stroke volume were lower in FMDM; 184 
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the differences in left ventricular stroke volume (LVSV), RVSV and SV between 185 
FMDM and FC became more apparent beyond 22 weeks (Figure 1A, 1B and 186 
1C).  187 
The results of the fitted organ and vessel parameters from the fetal 188 
cardiovascular lumped model have been presented in Table 3. There was 189 
redistribution of blood flow away from the brain toward the placenta in FMDM. 190 
There was an increase in model-based brain resistance (Rbrain/Rbrain0) (FMDM 191 
2.36 + 1.66, FC 1.60 + 0.85, p 0.03) (Table 3) with associated lower MCA blood 192 
volume (MCA_vol/SV) (Figure 2A, Table 2) in FMDM compared to FC. Aortic 193 
isthmus blood volume (AoI_vol/SV) (Figure 2B) was higher in FMDM (Table 2). 194 
Model-based placental resistance (Rplac/Rplac0) was significantly lower in 195 
FMDM compared to FC (0.59+0.5 vs. 0.91+0.41; p<0.05) (Table 3) with 196 
associated increased UA blood volume (UA_vol/SV) (Table 2). Thus, compositely 197 
there the cerebral placental blood volume ratio (MCA_vol/UA_vol) was lower in 198 
FMDM group (Table 2) (0.23+0.20 vs. 0.46+0.34; p 0.05).  199 
Model-based diameters of the cerebral arteries were significantly smaller 200 
compared to controls whereas aortic diameters were higher and umbilical arteries 201 
remained unchanged (Table 3, figure 3). No vessels or organ compliances were 202 
significantly altered. Pressures estimates by the model were not different at any 203 
location. No significant differences in the variables were noted when data was 204 
reevaluated after exclusion of FDM with maternal DM control on diet alone or 205 
after excluding FDM with maternal hypertension. No significant correlation was 206 
found between Rplac/Rplac0 (R2 = 1.3, p= 0.95) or Rbrain/Rbrain0 (R2 = 0.0234, 207 
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p= 0.49) to HgbA1c levels. When evaluating the relationship between GA and 208 
some of the model parameters, Rplac/Rplac0 was noted to slightly increase with 209 
increasing GA as is seen in all pregnancies (R2 = 0.221, p = 0.006) and no 210 
significant change was noted in Rbrain/Rbrain0 with GA (R2 = 0.125, p = 0.08). 211 
However, when considering the non-normalized values of both placenta and 212 
brain resistances (Rplac, Rbrain) the same results were observed (see 213 
supplementary figure). Moreover, when performing the linear regression analysis 214 
in their normal values (Rplac0, Rbrain0), no differences between control and 215 
FDMD groups were found (see supplementary figure), which suggest that 216 
differences in model-based parameters were not due to differences in GA 217 




The present investigation assessed circulatory remodeling in FMDM as 222 
compared to FC using a validated lumped model of the fetal circulation. Our key 223 
findings from the model are that placental resistance decreases in FMDM, (while 224 
compliance remains similar), and that cerebral resistance increases 225 
concomitantly. Consequently, there is a redistribution of blood flow predominantly 226 
towards the placenta, and diminished blood flow to the brain with concurrently 227 
with decreased SV.  228 
Morphological changes such as vascular anomalies, increased placental 229 
thickness and weight have commonly been seen in placentae of women with 230 
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DM.[7, 21] A higher release of cytokines, such Tumor Necrosis Factor-α, an 231 
upregulation of inflammation related genes, increased concentration of 232 
vasodilator endogenous nucleoside adenosine and increased vascular 233 
endothelial growth factor involvement have been noted in these placentae.[7, 11, 234 
12] Increased size, vascularization and vasodilatation in FMDM placentae 235 
support the decrease in placental resistance noted in our study and the resulting 236 
alterations in uterine artery flow. Interestingly, no change in placental compliance 237 
was found suggesting the absence of fibrosis of tissue damage altering vessel 238 
and tissue elasticity.  239 
In this study, we have shown that blood flow to the brain in FMDM is altered with 240 
higher brain resistance, lower MCA flow and lower relative cerebral placental 241 
blood volume. It is likely that these changes contribute to the functional and 242 
developmental neurological abnormalities in FMDM that are seen in postnatal 243 
life. Electroencephalograms performed on neonates of MDM have been 244 
described to have features suggestive of abnormal development of brain function 245 
that correlate to maternal diabetes control.[22] Abnormal visual evoked 246 
potentials, lower cognitive scores and lower gross and fine motor achievements 247 
as well as higher attention deficits are seen in children born to MDM.[6, 23]  248 
We noted decreased SV in FMDM compared to FC. In a previous publication, we 249 
have noted a subclinical decrease in myocardial deformation in FMDM that 250 
further supports this finding.[3] There have been limited publications that evaluate 251 
CO in MDM. Previous fetal MCA and UA Doppler studies have not been able to 252 
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demonstrate any changes in FMDM likely due to their limited and focused 253 
evaluations.[24, 25] 254 
The EFW in FMDM were comparable to FC. It is speculative if other circulatory 255 
abnormalities may be seen in FMDM who are large for gestational age or have 256 
evidence of intra-uterine growth retardation. The circulatory abnormalities in 257 
IUGR have been well characterized. A fascinating observation in this report was 258 
that, from 22 weeks GA, there seemed to a different trend in the change in 259 
circulatory parameters with GA between FMDM and FC (Figures 2-4). It is 260 
unknown if these alterations are a continuum of ongoing processes from the first 261 
trimester or if this GA represents a critical tipping point when the changes 262 
become irreversible.  263 
The observed decrease in stroke volume (and to a lesser extent cardiac output) 264 
is either related to myocardial dysfunction or to decreased demand from the 265 
peripheral organs. Given that there is no evidence of pressure overload and that 266 
the enlarged placenta, with increased flow, likely increases oxygenation and 267 
nutrition, a decreased demand is most likely. Interestingly, this seems to go 268 
together with a trend of a blunted decrease in organ resistances/diameters (in our 269 
model, the brain and coronaries, from literature, possibly the kidneys as well), 270 
ultimately resulting in the decreased organ flow as clearly illustrated in the brain 271 
in FMDM and potentially predisposing them to post-natal problems when 272 
oxygenation and nutrition normalizes.  273 
The present fetal circulation model does not account for changes that may occur 274 
because of other alterations in fetal milieu such as chemical and inflammatory 275 
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markers and genetic influences in FMDM. However, since we used patient 276 
specific data to build the model and its boundary conditions (GA, EFW, heart 277 
rate, Doppler velocities and valve radius) to estimate the specific hemodynamic 278 
parameters variation for each individual fetus, we believe this provides a 279 
reasonable estimate of the circulatory adaptations in FMDM. Limitations of the 280 
model have been discussed in a previous publication.[14] The changes described 281 
in this study may not be applicable to all trimesters of pregnancy in FMDM. 282 
Additionally, most mothers in the FDM group were well controlled. It is likely that 283 
some changes in the FDM were blunted because of the adequate glucose control 284 
in the mothers; it is speculative that the results may vary in the setting of 285 
inadequate maternal diabetes control. Despite these significant limitations, the 286 
novel application of these emerging methods suggests the potential for future 287 
applications in prospective studies. 288 
 289 
This study provides a comprehensive evaluation of the circulatory remodeling in 290 
FMDM using patient specific computational modeling. Increased cerebral 291 
resistance and decreased placental resistance contribute to the reversal of CPR 292 
that is unique to FMDM. The prognostic impact of these findings is unclear at the 293 
present time, however, we believe this study is utilitarian to future investigations.  294 
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Figure legends: 412 
Figure 1: Regression plots illustrating left ventricular stroke volume (LVSV)(1A), 413 
right ventricular stroke volume (RVSV) (1B) and total stroke volume (SV) (1C) as 414 
a function of gestation age (GA) 415 
 416 
Figure 2: Regression plots illustrating middle cerebral artery blood volume 417 
(MCA_vol)(2A) and aortic isthmus blood volume (AoI_vol) (2B) as a function of 418 
gestation age (GA) 419 
 420 
Figure 3: Regression plots illustrating the modelled vessel diameters (relative to 421 
the expected value for gestational age (GA) from literature) and their changes 422 
with GA:  A: aortic diameter (Ao_diam); B: cerebral artery diameter (cA_diam); C: 423 
umbilical artery diameter (uA_diam)  424 
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Table 1: Baseline maternal, fetal and neonatal characteristics in diabetic and 425 
control groups 426 





Gestational age at time 
of fetal echocardiogram 
(weeks)  
26.8+3.8 28.1+4.1 0.24 
Hemoglobin A1c  6.06+0.8% - - 
Maternal BMI 32.5+7.4 23.8+4.02 <0.001 
Estimated fetal weights 
(grams)  
1164+683 1371+688 0.58 
Birth weights (grams) 3411+554 3240+556 0.27 
 427 
  428 
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Table 2: Comparisons of (modeled and measured) flow related parameters 429 
between fetuses of mothers with diabetic mellitus (FMDM) and fetal controls (FC) 430 






LV_VTI (cm) 1.57 + 0.96 2.19 + 1.23 0.058§ 
RV_VTI (cm) 2.08 + 1.14 2.78 + 1.35 0.069§ 
LV_SV (ml) 1.57 + 0.96 2.19 + 1.23 0.058§ 
RV_SV (ml) 2.08 + 1.14 2.78 + 1.35 0.05* 
SV (ml) 3.65 + 2.05 4.97 + 2.45 0.04* 
RCO (ml/min) 303 + 165 391 + 183 0.07 
LCO (ml/min) 228 + 138 307 + 160 0.076§ 
CCO (ml/min) 531 + 295 698 + 326 0.06 





MCA_VTI (cm) 6.44 + 2.04 7.09 + 2.17 0.48 
MCA_vol (ml)‡ 0.12 + 0.14 0.27 + 0.21 0.01*§ 






AoI_VTI (cm) 11.6 + 2.07 11.29 + 2.62 0.82 
AoI_vol (ml)‡ 0.81 + 0.48 0.78 + 0.44 0.82 








UA_VTI (cm) 10.57 + 2.53  11.38 + 3.71 0.86 
UA_vol (ml)‡ 0.64 + 0.56 0.56 + 0.27 0.54 
UA_vol/SV (%)‡ 34.1 + 15.94 25.32 + 11.7 0.01*§ 
MCA_vol/UA_vol‡ 0.23 + 0.20 0.46 + 0.34 0.01*§ 
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LV_VTI: Velocity time integral (VTI) of left ventricular outflow tract Doppler, 431 
RV_VTI: VTI of right ventricular outflow tract Doppler, LV_SV: Left ventricular 432 
stroke volume, RV_SV: Right ventricular stroke volume, SV: Stroke volume, 433 
RCO: Right ventricular cardiac output, LCO: Left Ventricular cardiac output, 434 
CCO: Combined left and right ventricular cardiac output, HR: Heart rate 435 
MCA_VTI: VTI of middle cerebral artery Doppler, MCA_vol: Middle cerebral 436 
artery blood volume/heartbeat, AoI_VTI: VTI of aortic isthmus Doppler, AoI_vol: 437 
Aortic isthmus blood volume/heartbeat, UA_VTI: VTI of umbilical arterial Doppler,  438 
UA_vol: Umbilical Artery blood volume/heartbeat , ‡ Modeled variables,  439 
*Significant p < 0.05, § not-normally distributed. 440 
  441 
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Table 3: Comparisons of the modeled vessel diameters, organ resistances and 442 
compliances between fetuses of mothers with diabetic mellitus (FMDM) and fetal 443 
controls (FC)  444 
Variable FMDM (n=23) FC (n=31) p value 
Rplac/Rplac0 0.59 + 0.5 0.91 + 0.41 <0.01*§ 
Cplac/Cplac0 1.54+0.78  2.12+1.35 0.07 
Rbrain/Rbrain0 2.36 + 1.66 1.60 + 0.85 0.03* 
Cbrain/Cbrain0 0.43+0.46 0.40+0.25 0.74 
RcorA/RcorA0 1.64 + 0.60 1.65 + 1.10 0.09§ 
D_Aorta/D_Aorta0 1.19 + 0.25 1.07 + 0.14 0.05*2*§ 
C_Aorta/C_Aorta0 2.49+0.90 2.69+1.12 0.48 
D_cerA/D_cerA0 0.73 + 0.25 1.00 + 0.33 < 0.01*§ 
C_cerA/C_cerA0 1.04+1.26 0.75+0.67 0.28 
D_UA/D_UA0 1.18 + 0.32 1.10 + 0.19 0.35 
C_UA/CUA0 1.87+1.14 1.80+0.84 0.80 
Rplac: Placental resistance, Cplac: Placental compliance, Rbrain: Brain 445 
resistance, Cbrain: Brain compliance, RcorA: Coronary arteries resistance, 446 
D_Aorta: Aorta diameter, C_Aorta: Aorta compliance, D_cerA: Cerebral arteries 447 
diameter, C_cerA: Cerebral arteries compliance, D_UA: Umbilical arteries 448 
diameter, C_UA: Umbilical arteries compliance, * Significant p < 0.05, § not-449 
normally distributed.  450 
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Table 4: Linear Regression Analysis of Fetuses of Mothers with Diabetes 451 
Mellitus (FMDM) and Fetal Controls (FC) 452 
Variable R2 FMDM (n=23) R2 FC (n=31) 
Rplac/Rplac0 0.055 0.188 
Rbrain/Rbrain0 0.024 0.095 
RcorA/RcorA0 0.099 0.528 
LV_SV 0.615 0.753 
RV_SV 0.707 0.783 
MCA_vol 0.395 0.596 
AoI_vol 0.412 0.467 
UA_vol 0.314 0.422 
CCO 0.685 0.849 
Rplac: Placental resistance, Rbrain: Brain resistance, RcorA: Coronary arteries 453 
resistance, LV_SV: Left ventricular stroke volume cardiac output, RV_SV: Right 454 
ventricular stroke volume, MCA_vol: Middle cerebral artery blood 455 
volume/heartbeat, AoI_vol: Aortic isthmus blood volume/heartbeat, UA_vol: 456 
Uterine Artery blood volume/heartbeat, CCO: Combined left and right ventricular 457 
cardiac output. 458 
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